Literature DB >> 25313324

Comparison of the Cardiac MicroPET Images Obtained Using [(18)F]FPTP and [(13)N]NH3 in Rat Myocardial Infarction Models.

Dong-Yeon Kim1, Hyeon Sik Kim1, Hwa Youn Jang1, Ju Han Kim2, Hee-Seung Bom1, Jung-Joon Min1.   

Abstract

The short half-life of current positron emission tomography (PET) cardiac tracers limits their widespread clinical use. We previously developed a (18)F-labeled phosphonium cation, [(18)F]FPTP, that demonstrated sharply defined myocardial defects in a corresponding infarcted myocardium. The aim of this study was to compare the image properties of PET scans obtained using [(18)F]FPTP with those obtained using [(13)N]NH3 in rat myocardial infarction models. Perfusion abnormality was analyzed in 17 segments of polar map images. The myocardium-to-liver and myocardium-to-lung ratios of [(18)F]FPTP were 10.48 and 2.65 times higher, respectively, than those of [(13)N]NH3 in images acquired 30 min after tracer injection. The myocardial defect size measured by [(18)F]FPTP correlated more closely with the hypoperfused area measured by quantitative 2,3,5-triphenyltetrazolium chloride staining (r = 0.89, P < 0.01) than did [(13)N]NH3 (r = 0.84, P < 0.01). [(18)F]FPTP might be useful as a replacement for the myocardial agent [(13)N]NH3 in cardiac PET/CT applications.

Entities:  

Keywords:  18F-labeled phosphonium salt; Myocardial imaging agent; [13N]ammonia; myocardial infarction; positron emission tomography (PET)

Year:  2014        PMID: 25313324      PMCID: PMC4190622          DOI: 10.1021/ml500251z

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  25 in total

1.  Evaluation of (99)  (m)TcN-MPO as a new myocardial perfusion imaging agent in normal dogs and in an acute myocardial infarction canine model: comparison with (99)  (m)Tc-sestamibi.

Authors:  Lihong Bu; Renfei Li; Zhongnan Jin; Xiaofei Wen; Shuang Liu; Baofeng Yang; Baozhong Shen; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

Review 2.  Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology.

Authors:  M F Ross; G F Kelso; F H Blaikie; A M James; H M Cochemé; A Filipovska; T Da Ros; T R Hurd; R A J Smith; M P Murphy
Journal:  Biochemistry (Mosc)       Date:  2005-02       Impact factor: 2.487

Review 3.  Positron emission tomography and molecular imaging.

Authors:  J Knuuti; F M Bengel
Journal:  Heart       Date:  2008-03       Impact factor: 5.994

Review 4.  Selective targeting of bioactive compounds to mitochondria.

Authors:  M P Murphy
Journal:  Trends Biotechnol       Date:  1997-08       Impact factor: 19.536

5.  Synthesis of [¹⁸F]-labeled (2-(2-fluoroethoxy)ethyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography.

Authors:  Dong-Yeon Kim; Hee-Jung Kim; Kook-Hyun Yu; Jung-Joon Min
Journal:  Bioorg Med Chem Lett       Date:  2011-11-10       Impact factor: 2.823

6.  Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13N-ammonia PET/CT.

Authors:  Piotr J Slomka; Erick Alexanderson; Rodrigo Jácome; Moises Jiménez; Edgar Romero; Aloha Meave; Ludovic Le Meunier; Magnus Dalhbom; Daniel S Berman; Guido Germano; Heinrich Schelbert
Journal:  J Nucl Med       Date:  2012-01-06       Impact factor: 10.057

7.  Cardiological applications of nuclear medicine.

Authors:  M Schwaiger; J Melin
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

8.  Tetraphenylphosphonium as a novel molecular probe for imaging tumors.

Authors:  Jung-Jun Min; Sandip Biswal; Christophe Deroose; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

9.  Assessment of severity of coronary artery stenosis in a canine model using the PET agent 18F-fluorobenzyl triphenyl phosphonium: comparison with 99mTc-tetrofosmin.

Authors:  Igal Madar; Hayden Ravert; Antony Dipaula; Yong Du; Robert F Dannals; Lewis Becker
Journal:  J Nucl Med       Date:  2007-05-15       Impact factor: 10.057

10.  Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease.

Authors:  Uchechukwu K Sampson; Sharmila Dorbala; Atul Limaye; Raymond Kwong; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2007-02-26       Impact factor: 24.094

View more
  5 in total

Review 1.  Emerging Tracers for Nuclear Cardiac PET Imaging.

Authors:  Dong-Yeon Kim; Sang-Geon Cho; Hee-Seung Bom
Journal:  Nucl Med Mol Imaging       Date:  2018-05-08

Review 2.  KSNM60 in Cardiology: Regrowth After a Long Pause.

Authors:  Sang-Geon Cho; Eun Jung Kong; Won Jun Kang; Jin Chul Paeng; Hee-Seung Henry Bom; Ihnho Cho
Journal:  Nucl Med Mol Imaging       Date:  2021-06-08

Review 3.  KSNM60: The History of Radiopharmaceutical Sciences in Korea.

Authors:  Ran Ji Yoo; Yun-Sang Lee; Kyo Chul Lee; Dong Wook Kim; Dong-Yeon Kim; Yearn Seong Choe; Jae Min Jeong
Journal:  Nucl Med Mol Imaging       Date:  2022-04-05

Review 4.  Radiolabeled Phosphonium Salts as Mitochondrial Voltage Sensors for Positron Emission Tomography Myocardial Imaging Agents.

Authors:  Dong-Yeon Kim; Jung-Joon Min
Journal:  Nucl Med Mol Imaging       Date:  2016-02-29

5.  Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP.

Authors:  Ji Who Kim; Seongho Seo; Hyeon Sik Kim; Dong-Yeon Kim; Ho-Young Lee; Keon Wook Kang; Dong Soo Lee; Hee-Seung Bom; Jung-Joon Min; Jae Sung Lee
Journal:  Ann Nucl Med       Date:  2017-04-25       Impact factor: 2.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.